- CEO
- Li Fen Lo
- Full Time Employees
- 547
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- No. 21, Longxiang Road Zhangzhou FU China KY1-1104
- IPO Date
- Nov 19, 2018
- Business
- Luo Lih-Fen Holding Co., Ltd. Luo Lih-Fen Holding Co., Ltd. (6666.TW) is a Cayman Islands-incorporated holding company founded in 2016 and headquartered in Grand Cayman that, through its subsidiaries, primarily engages in the research, development, manufacture, and sale of skincare and beauty care products in Taiwan and Mainland China. The company offers a diverse portfolio of facial beauty care products including facial cleansers, toners, essences, face creams, masks, eye kits, facial kits, health preservation kits, and oral health preservation foods; beauty care instruments and medical devices; raw materials, semi-finished products, and packaging materials; under brands such as LUO LIH-FEN, GLINGLUO, SUNLILY, DRAISE, QIECOME, EASYBIO, MALLSKIN, and YIN-NI. It also provides beauty and skincare consulting services, medical cosmetology services, operates and manages healthcare and biocare beauty salons including the RUILIJIA chain across the Taiwan Strait, and conducts general investment and real estate leasing activities, with primary manufacturing through Juwenlee (Fujian) Cosmetics Co., Ltd. in Zhangzhou Taiwanese Investment Zone, Fujian Province, China. Recent developments include the establishment of subsidiaries such as Xiamen Binnange Property Management Co., Ltd. in 2023 for asset utilization; Juliying (FuJian) Bio-Technology Co., Ltd. in 2023 to expand daily cosmetics sales; Xiamen Jialifenni Beauty Co., Ltd. and Juliying (Xiamen) Health Technology Co., Ltd. in 2024 for chain systems and skincare sales growth; Xiamen Siming District Ruilifenni Medical Beauty Clinic Co., Ltd. in 2024 to broaden sales channels; capital reduction and subsequent increase for Lever Guide Biotech Co., Ltd. in 2024 to improve financial structure; and a capital increase for Juwenlee (Fujian) Cosmetics Co., Ltd. in November 2024 via capitalization to replenish working capital.